Osteoporosis Medication May Not Protect You Against Osteoarthritis: Study

Medications commonly prescribed for osteoporosis may not offer the same protection against osteoarthritis as previously hoped, according to a new study published in the BMJ Journal. Researchers investigating oral bisphosphonates, drugs widely used to improve bone strength and reduce fracture risk, found that they may not significantly lower the risk of developing osteoarthritis in people with osteoporosis. The findings are important because osteoarthritis and osteoporosis often affect older adults together, leading scientists to explore whether treatments targeting bone health could also benefit joint health. Experts say the study highlights the need for separate strategies to manage these two common age-related conditions.

What Are Bisphosphonates?

Osteoarthritis and osteoporosis are among the most common musculoskeletal disorders in older adults, posing a significant public health challenge. In 2019, osteoarthritis alone affected an estimated 528 million people worldwide, underscoring its widespread prevalence and burden. Bisphosphonates are a class of medications used to slow bone loss and strengthen bones in people with osteoporosis. Common examples include:

• Alendronate
• Risedronate
• Ibandronate
• Zoledronate

These medications are mainly prescribed to reduce fracture risk in older adults, especially postmenopausal women.

Also read: Women Are Losing Bone Strength Much Earlier Than Expected, Doctor Explains Why

What Did The Study Find?

Researchers found that oral bisphosphonate use did not significantly reduce the likelihood of developing osteoarthritis among patients with osteoporosis. This challenges earlier theories suggesting these drugs might help protect joints by influencing bone changes linked to osteoarthritis progression.

Why Scientists Thought They Might Help

Previous research had suggested bisphosphonates could affect bone marrow lesions and other structural changes associated with osteoarthritis pain and joint damage. Because bones and joints are closely connected, scientists hoped osteoporosis treatments might also slow cartilage degeneration or inflammation in joints. However, the latest findings suggest the relationship may be more complex.

What Is The Difference Between Osteoporosis And Osteoarthritis?

Although the conditions sound similar, they affect the body differently.

• Osteoporosis
• Causes bones to become weak and fragile
• Increases fracture risk

Osteoarthritis

• Involves wear and tear of joint cartilage
• Causes pain, stiffness, and reduced mobility

Many older adults may develop both conditions at the same time.

Why This Matters For Older Adults

Osteoarthritis remains one of the leading causes of pain and disability worldwide. Experts say people with osteoporosis should not assume their medications will automatically protect joint health as well. Managing osteoarthritis may still require:

• Weight management
• Exercise and physiotherapy
• Pain management strategies
• Joint-specific treatment approaches

Also read: Can You Treat Osteoporosis? Have A Look At Some Natural Ways To Build Healthy Bones

Are Bisphosphonates Still Effective?

Researchers emphasise that bisphosphonates remain highly effective for reducing fracture risk and treating osteoporosis when used appropriately. The study only suggests they may not significantly prevent osteoarthritis. While osteoporosis medications play a crucial role in protecting bone health, the latest research suggests they may not reduce the risk of osteoarthritis in people with osteoporosis. Experts say patients should continue prescribed osteoporosis treatment but also focus separately on joint health through exercise, healthy weight management, and regular medical care.

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.